<

 
Data updated 2025-05-12 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date11189346.7 (espacenet)  (Federated)  (European Patent Register), 20060411
Patent/reg. no. and dateDK/EP 2420234, 20130710
Publication date20120222
Priority no. and dateUS 670204 P, 20050411
EP pub. no. and date EP 2420234 20120222
Effective date
Applicant/ownerAbbVie Ireland Unlimited Company, 70 Sir John Rogerson's Quay
Dublin 2
Dublin, D02 R296
, IE
Applicant ref. no.P012894EPDK1 EJ/GB
InventorZhu, Guidong, 1395 Almaden Ln
Gurnee, IL Illinois 60031, US,
Gong, Jianchun, 130 Ferndale Rd
Deerfield, IL Illinois 60015, US,
Gandhi, Virajkumar, B., 5335 Mahogany Ct.
Gurnee, IL Illinois 60031, US,
Penning, Thomas, D., 321 Highview
Elmhurst, IL Illinois 60126, US,
Giranda, Vincent, 272 S Fork Dr
Gurnee, IL Illinois 60031, US
RepresentativeCHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK
Opponent
IPC ClassA61K 31/4184 (2006.01) , A61K 31/454 (2006.01) , A61K 31/55 (2006.01) , A61P 9/10 (2006.01) 
Title1H-benzimidazol-4-carboxamider substitueret med et kvaternært carbon i 2-stillingen som PARP-inhibitorer til anvendelse ved behandling af cancer
Int. application no.
Int. publication no.
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact